Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 231

1.

Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues.

Miliani de Marval PL, Macias E, Rounbehler R, Sicinski P, Kiyokawa H, Johnson DG, Conti CJ, Rodriguez-Puebla ML.

Mol Cell Biol. 2004 Sep;24(17):7538-47.

2.

Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.

Reynisdóttir I, Polyak K, Iavarone A, Massagué J.

Genes Dev. 1995 Aug 1;9(15):1831-45.

3.

Cdk2 deficiency decreases ras/CDK4-dependent malignant progression, but not myc-induced tumorigenesis.

Macias E, Kim Y, Miliani de Marval PL, Klein-Szanto A, Rodriguez-Puebla ML.

Cancer Res. 2007 Oct 15;67(20):9713-20.

4.
5.

Skp2 is necessary for Myc-induced keratinocyte proliferation but dispensable for Myc oncogenic activity in the oral epithelium.

Sistrunk C, Macias E, Nakayama K, Kim Y, Rodriguez-Puebla ML.

Am J Pathol. 2011 Jun;178(6):2470-7. doi: 10.1016/j.ajpath.2011.02.034.

7.

Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.

Hsieh FF, Barnett LA, Green WF, Freedman K, Matushansky I, Skoultchi AI, Kelley LL.

Blood. 2000 Oct 15;96(8):2746-54.

8.
9.

Investigation of the cell cycle regulation of cdk3-associated kinase activity and the role of cdk3 in proliferation and transformation.

Braun K, Hölzl G, Soucek T, Geisen C, Möröy T, Hengstschläger M.

Oncogene. 1998 Oct 29;17(17):2259-69.

10.

Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc.

Vlach J, Hennecke S, Alevizopoulos K, Conti D, Amati B.

EMBO J. 1996 Dec 2;15(23):6595-604.

11.

New functional activities for the p21 family of CDK inhibitors.

LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E.

Genes Dev. 1997 Apr 1;11(7):847-62.

12.
14.
16.
17.
18.

Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours.

Coppée F, Depoortere F, Bartek J, Ledent C, Parmentier M, Dumont JE.

Oncogene. 1998 Aug 6;17(5):631-41.

19.

Cyclin-dependent kinase (cdk) inhibitors/cdk4/cdk2 complexes in early stages of mouse mammary preneoplasia.

Said TK, Moraes RC, Singh U, Kittrell FS, Medina D.

Cell Growth Differ. 2001 Jun;12(6):285-95.

20.

Cdk4 deficiency inhibits skin tumor development but does not affect normal keratinocyte proliferation.

Rodriguez-Puebla ML, Miliani de Marval PL, LaCava M, Moons DS, Kiyokawa H, Conti CJ.

Am J Pathol. 2002 Aug;161(2):405-11.

Supplemental Content

Support Center